Table 1.
Electrode | Nanomaterials | Biomarker | Assay Type | Technique(s) | Sample(s) | Linear Range | LOD | Reference |
---|---|---|---|---|---|---|---|---|
Pt-electrode | N,S–GQDs/Au–PANI | CEA | Direct | EIS | Human serum | 0.5–1000 ng mL−1 | 0.01 ng mL−1 | [122] |
GCE | PtPd/N–GQDs/Au | CEA | Direct | Amperometry | Human serum | 5 fg mL−1–50 ng mL−1 | 2 fg mL−1 | [67] |
GCE | P5FIn/erGO/GQDs/Au | CEA | Sandwich | ECL | Human serum | 0.1–10 ng mL−1 | 3.78 fg mL−1 | [123] |
SPCE | MWCNTs/GQDs | IL-13Rα2 | Sandwich | Amperometry | Raw cellular lysates from human CRC | 2.7–100 ng mL−1 | 0.8 ng mL−1 | [124] |
SPdCE | MWCNTs/GQDs | IL-13Rα2, CDH-17 |
Sandwich | Amperometry | Raw cellular lysates from human CRC and breast cancer | 4.92–100 ng mL−1 (IL-13sRα2) 0.11–10 ng mL−1 (CDH-17) |
1.44 ng mL−1 (IL-13sRα2) 0.03 ng mL−1 (CDH-17) | [112] |
SPCE | N,S–GQDs/AuNPs | HCG | Direct | CV, SWV, EIS | Human serum | 0.1–125 pg mL−1 | 12.5 fg mL−1 | [61] |
Au-electrode | P-Cys/GQDs/AuNPs | p53 | Direct | SWV, DPV | Human plasma | 0.0488–12.5 pM | 23.4 fM | [125] |
GCE | CysA/AuNPs/GQDs | CA 15-3 | Direct | SWV, CV | Human plasma; cellular lysates from human breast cancer | 0.16–125 U mL−1 | 0.11 U mL−1 | [126] |
GCE | Au/Ag–rGO/GQDs | PSA | Direct | EIS, ECL | Human serum | 1 pg–10 ng mL−1 | 0.29 pg mL−1 | [127] |
GCE | GQD/GS | PSA | Sandwich | SWV | Human serum | 0.005–10 ng mL−1 | 3 pg mL−1 | [128] |
GCE | GN–Ag–Au/GQDs | CA 199 | Sandwich | ECL | Human serum | 0.002–70 U mL−1 | 0.96 mU mL−1 | [129] |
Abbreviations: Ag: Silver; AuNPs: Gold nanoparticles; CA 15-3: Carcinoma antigen 15-3; CA 199: Carbohydrate antigen 199; CEA: Carcinoembryogenic antigen; CDH-17: Cadherin-17; CRC: Colorectal cancer; CV: Cyclic voltammetry; CysA: Cysteamine; DPV: Differential pulse voltammetry; ECL: Electrochemiluminescence; EIS: Electron impedance spectroscopy; erGO: Electrochemically reduced graphene oxide; GCE: Glassy carbon electrode; GN: Graphene; GS: Graphene sheets; GQDs: Graphene quantum dots; HCG: Human chorionic gonadotropin; IL-13Rα2: Interleukin-13 receptor α2; MWCNTs: Multi-walled carbon nanotubes; N,S–GQDs: Nitrogen- and thiol-doped graphene quantum dots; p53: Tumor protein-53; P5FIn: Poly(5-formylindole); PANI: Polyaniline; P-Cys: Poly L-cysteine; Pd: Palladium; PSA: Prostate-specific antigen; Pt: Platinum; r-GO: Reduced graphene oxide; SPCE: Screen-printed carbon electrode; SPdCE: Screen-printed dual carbon electrode; SWV: Square wave voltammetry.